Key facts
- It has raised $17.2M; the latest was Later Stage VC ($250K) in Jul 2025.
- Notable investors include Cadron Capital Partners.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for OurPharma
- ·The full record, as it builds
Funding rounds
No funding rounds for OurPharma are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About OurPharma
Operator of a pharmaceutical company intended to address the need for medications that are in short supply regionally and nationally. The company's products include a wide range of medications provided in syringes, injection vials, intravenous bags and CADD cassettes, enabling healthcare organizations to address their shortages.
- Sector
- Healthcare
- HQ
- Fayetteville, AR, United States
- Founded
- 2016
- Employees
- 51
- Website
- ourpharma.net/
- Ownership
- Privately Held (backing)
OurPharma doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in OurPharma shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on OurPharma in its N-PORT filings yet. We sweep new filings monthly.